Prognosis of Treatment Response (Pathological Complete Response) in Breast Cancer

Prognosis of Treatment Response (Pathological Complete Response) in Breast Cancer

Show other versions (1)

Pertaining to the female population in the USA, breast cancer is the leading cancer in terms of annual incidence rate and, in terms of mortality, the second most lethal cancer. There are currently no biomarkers available that can predict which breast cancer patients will respond to chemotherapy with...

Full description

Bibliographic Details
Main Authors:	Jason B. Nikas, Walter C. Low, Paul A. Burgio
Format:	Article
Language:	English
Published:	SAGE Publishing 2012-01-01
Series:	Biomarker Insights
Online Access:	https://doi.org/10.4137/BMI.S9387

Similar Items

Prognosis of Treatment Response (Pathological Complete Response) in Breast Cancer
by: Jason B. Nikas, et al.
Published: (2012-05-01)

Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
by: Paul Gass, et al.
Published: (2018-10-01)

Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer
by: Gonzalez-Angulo Ana M, et al.
Published: (2011-07-01)

Conversion of immunohistochemical markers and breast density are associated with pathological response and prognosis in very young breast cancer patients who fail to achieve a pathological complete response after neoadjuvant chemotherapy
by: Zhao Y, et al.
Published: (2019-06-01)

Relevance of Pathological Complete Response after Neoadjuvant Therapy for Breast Cancer
by: Angela Pennisi, et al.
Published: (2016-01-01)

Relevance of Pathological Complete Response after Neoadjuvant Therapy for Breast Cancer
by: Angela Pennisi, et al.
Published: (2016-07-01)

Mathematical Prognostic Biomarker Models for Treatment Response and survival in Epithelial Ovarian Cancer
by: Jason B. Nikas, et al.
Published: (2011-01-01)

Mathematical Prognostic Biomarker Models for Treatment Response and Survival in Epithelial Ovarian Cancer
by: Jason B. Nikas, et al.
Published: (2011-10-01)

Construction of Nomograms for Predicting Pathological Complete Response and Tumor Shrinkage Size in Breast Cancer
by: Yan S, et al.
Published: (2020-09-01)

Evaluation of the pathological response and prognosis following neoadjuvant chemotherapy in molecular subtypes of breast cancer
by: Zhao Y, et al.
Published: (2015-06-01)

MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer
by: Briete Goorts, et al.
Published: (2018-04-01)

Metabolic Syndrome and Breast Cancer: Prevalence, Treatment Response, and Prognosis
by: Shuwen Dong, et al.
Published: (2021-03-01)

Predictive factors of achievement pathological complete response at neoadjuvant chemotherapy of primary operable breast cancer
by: O A Pavlikova, et al.
Published: (2017-01-01)

Androgen Receptor Expression in Locally Advanced Breast Cancer Predicts Lack of Pathological Complete Response After Neoadjuvant Treatment
by: allan Ramos-Esquivel, et al.
Published: (2017-12-01)

MRI-PATHOLOGICAL PARALLELS WITH THE COMPLETE TUMOR RESPONSE TO NEOADJUVANT CHEMORADIATION TREATMENT OF RECTAL CANCER
by: T. P. Berezoskaya, et al.
Published: (2019-06-01)

Impact of Pathologic Complete Response following Neoadjuvant Chemotherapy ± Trastuzumab in Locally Advanced Breast Cancer
by: Taher Al-Tweigeri, et al.
Published: (2021-01-01)

Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy
by: Jie Dong, et al.
Published: (2021-06-01)

Predicting pathological complete response in the axilla post neoadjuvant chemotherapy in carcinoma breast
by: A. AbduRahman, et al.
Published: (2021-04-01)

Assessment of pathological complete response using vacuum assisted biopsy in breast cancer patients who have clinical and radiological complete response after neoadjuvant chemotherapy
by: S. Khare, et al.
Published: (2021-04-01)

Predicting prognosis and drug response in breast cancer
by: Holt, S.
Published: (1984)

Linear Discriminant Functions in connection with the micro-RNA Diagnosis of Colon Cancer
by: Jason B. Nikas, et al.
Published: (2012-01-01)

Linear Discriminant Functions in Connection with the micro-RNA Diagnosis of Colon Cancer
by: Jason B. Nikas, et al.
Published: (2011-12-01)

Prediction of Pathologic Complete Response by Ultrasonography and Magnetic Resonance Imaging After Neoadjuvant Chemotherapy in Patients with Breast Cancer
by: Zhang K, et al.
Published: (2020-04-01)

Prediction of Pathological Complete Response after Neoadjuvant Chemotherapy for breast cancer using ensemble machine learning
by: Raghvi Bhardwaj, et al.
Published: (2019-01-01)

Hormone receptor-negative as a predictive factor for pathologic complete response to neoadjuvant therapy in breast cancer
by: Luana Carolina Ferreira Fiuza Silva, et al.

Platelet-to-lymphocyte ratio as a predictive factor of complete pathologic response to neoadjuvant chemotherapy in breast cancer.
by: Javier Cuello-López, et al.
Published: (2018-01-01)

The implications of a pathological complete response of the primary tumour after neoadjuvant chemotherapy for breast cancer on axillary surgery
by: Mina M. G. Youssef, et al.
Published: (2021-02-01)

Neoadjuvant chemotherapy with trastuzumab in HER2-positive breast cancer: pathologic complete response rate, predictive and prognostic factors
by: I.P.C. Buzatto, et al.

A machine learning model that classifies breast cancer pathologic complete response on MRI post-neoadjuvant chemotherapy
by: Elizabeth J. Sutton, et al.
Published: (2020-05-01)

Microcalcifications after neoadjuvant chemotherapy for breast cancer in women achieving pathologic complete response of the invasive disease: do they matter?
by: T.J. Gagliardi, et al.
Published: (2021-04-01)

The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials
by: Monika Graeser, et al.
Published: (2021-10-01)

A nomogram based on clinicopathological features and serological indicators predicting breast pathologic complete response of neoadjuvant chemotherapy in breast cancer
by: Yijun Li, et al.
Published: (2021-05-01)

Impact of age on pathological complete response and locoregional recurrence in locally advanced breast cancer after neoadjuvant chemotherapy
by: Hsu-Huan Chou, et al.
Published: (2019-02-01)

Predictive ability of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for pathological complete response and prognosis after neoadjuvant chemotherapy in triple-negative breast cancer patients
by: Sachiko Kiyoto, et al.
Published: (2016-01-01)

THE RATE OF PATHOLOGICAL COMPLETE RESPONSE AND LONG-TERM OUTCOMES OF COMBINED TREATMENT FOR MIDDLE AND LOW RECTAL CANCER
by: S. M. Demidov, et al.
Published: (2015-02-01)

Pathological complete response in early stage HER-2 positive breast cancer patients, receiving neoadjuvant chemotherapy/ Trastuzumab, in a single breast unit in Johannesburg
by: A. Bellomo, et al.
Published: (2021-04-01)

Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers
by: Miao Ruan, et al.
Published: (2018-08-01)

Complete pathological response in patients with locally advanced cancer of breast and positive Her2/neu with neoadjuvant chemotherapy
by: de Torraza Idalmis, et al.
Published: (2007-02-01)

Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using a deep learning (DL) method
by: Yu‐Hong Qu, et al.
Published: (2020-03-01)

Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers
by: Kadri Altundag
Published: (2017-05-01)